Boehringer backs vaccines with $80m expansion in Georgia and Missouri
Boehringer Ingelheim Vetmedica (BIVI) is pre-empting an increased demand for veterinary vaccines by spending $80 million on expanding its existing facilities in Athens, Georgia and St Joseph, Missouri.